- In October 2022, the commercialization of novel automated co-detection assays created particularly for the Roche DISCOVERY ULTRA Platform, allowing simultaneous identification of RNA and protein on the same tissue section, was announced by Bio-Techne Corporation as part of the further development of the Advanced Cell Diagnostics-branded RNAscope in ISH portfolio. Theradiag SA will provide autoimmune reagents and quality controls, while Quotient Limited is expected to grow its MosaiQ platform.
- in April 2021, Bio-Techne announced the commercial launch of its Novel DNAscope ISH assay for chromogenic detection of structural variations and DNA copy numbers. Unlike others, the commercially available assays, DNAScope enables high resolution and targeted detection of small genomic regions or single gene locus with its proprietary signal amplification system coupled with oligo probes.
